Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion type Assertion NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_head.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion evidence source_evidence_literature NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion SIO_000772 18026833 NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion wasDerivedFrom befree-2016 NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.
- NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_assertion wasGeneratedBy ECO_0000203 NP641344.RAFpxJgLcYjJn7K0NjlKsebyMkp2eAVd8yYXmqOVS5FXQ130_provenance.